The first aim of this study is to determine the feasibility of delivering CO-OP remotely to breast cancer survivors, who self-report cancer-related cognitive impairment (CRCI), in preparation for a future R01 trial. The second aim of this study is to assess the effect of CO-OP on activity performance, subjective and objective cognition, and quality of life in a sample of breast cancer survivors who self-report CRCI. The research team hypothesizes that effect size estimations will indicate that CO-OP will have a greater positive effect, compared to attention control, on activity performance, subjective and objective cognition, and quality of life in a sample of breast cancer survivors who self-report CRCI.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Telehealth Usability Questionnaire (TUQ)
Timeframe: After study completion, an average of 14 weeks
Acceptability of Intervention Measure (AIM)
Timeframe: After study completion, an average of 14 weeks
Intervention Appropriateness Measure (IAM)
Timeframe: After study completion, an average of 14 weeks
Feasibility of Intervention Measure (FIM)
Timeframe: After study completion, an average of 14 weeks
Canadian Occupational Performance Measure (COPM) Trained Goal Performance
Timeframe: Pre-intervention (week 0) and post-intervention (week 14)
NeuroQoL Cognitive Function Short Form
Timeframe: Pre-intervention (week 0) and post-intervention (week 14)
Canadian Occupational Performance Measure (COPM) Trained Goal Satisfaction
Timeframe: After study completion, an average of 14 weeks